Pictet Asset Management (UK)’s Apellis Pharmaceuticals APLS Stock Holding History

Pictet Asset Management (UK)’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$259K	Buy	+4,100	New	+$212K	﹤0.01%	1504
2021 Q1	–	Sell	-4,800	Closed	-$275K	–	1795
2020 Q4	$275K	Buy	+4,800	New	+$203K	﹤0.01%	1446
2020 Q1	–	Sell	-37,386	Closed	-$1.15M	–	1131
2019 Q4	$1.15M	Sell	37,386 -35,533	-49%	-$983K	﹤0.01%	977
2019 Q3	$1.76M	Buy	72,919 +7,725	+12%	+$213K	﹤0.01%	881
2019 Q2	$1.65M	Buy	+65,194	New	+$1.33M	﹤0.01%	884

Other funds holding APLS

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Pictet Asset Management (UK)'s APLS Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Apellis Pharmaceuticals (APLS) in Q2 2021: 4,100 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #1504 among its holdings. This is a return to the name: Pictet Asset Management (UK) previously reported a position in APLS as recently as Q4 2020.

Pictet Asset Management (UK) first reported a position in APLS in Q2 2019 and has held it in 5 quarters since. The position peaked at $1.76M in Q3 2019. 204 funds tracked by Wall St. Rank hold APLS as of Q2 2021.

Pictet Asset Management (UK) held 4,100 shares of Apellis Pharmaceuticals worth $259K as of Q2 2021.
Apellis Pharmaceuticals was a new Pictet Asset Management (UK) position in Q2 2021.
Apellis Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1504 holding.
Pictet Asset Management (UK) first reported a position in Apellis Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
Pictet Asset Management (UK)'s Apellis Pharmaceuticals position peaked at $1.76M in Q3 2019.
204 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.